Plate Nº 30 · recorded October 10, 2026
Health & Medicine ResearchReported finding
Malaria, pneumonia, diarrhea lead child deaths in Sierra Leone
A Lancet Global Health study from the ICARIA project identifies malaria, respiratory infections, and diarrhea as the leading causes of hospital admission and death among children under two in Sierra Leone.
By Elena Vasquez3 min read581 words
In brief
- Published in The Lancet Global Health as part of the ICARIA project, led by ISGlobal with support from the "la Caixa" Foundation
- Malaria, respiratory infections, and diarrhea are the top three causes of hospital admission and death in Sierra Leone's under-twos
- Sierra Leone continues to record one of the highest child mortality rates in the world
- The study is prospective, tracking children from birth through age two
- The main preventive strategies for these diseases are already in place, yet mortality remains high
A prospective study tracking children in Sierra Leone has identified malaria, respiratory infections, and diarrhea as the three leading causes of hospitalization and death during the first two years of life. The findings, published in The Lancet Global Health, come from the ICARIA project, led by ISGlobal, a research center supported by the "la Caixa" Foundation.
The result carries weight because Sierra Leone continues to record one of the highest child mortality rates in the world, even after rolling out the main preventive strategies currently available for those conditions. The study underscores how much ground remains before childhood survival in the West African country approaches regional or global averages.
What did the ICARIA project track?
ICARIA followed children from birth through age two, recording every hospital admission and in-hospital death. Observing a cohort over time, rather than reviewing past records, gives researchers a clearer view of how often these illnesses send children to the hospital and how often those visits end in death.
The team focused on the three conditions that global health agencies have long treated as the main drivers of young-child mortality in low-income countries. Each can become life-threatening within hours when diagnosis and treatment arrive too late.
Why do these three diseases dominate?
Malaria, transmitted by mosquitoes, remains endemic across much of sub-Saharan Africa, and young children face repeated infections because they have not yet developed partial immunity. Respiratory infections — most often pneumonia — spread through coughs and contaminated surfaces. Diarrheal illness typically follows exposure to unsafe water, food, or hands.
Treatments exist for all three: antimalarial drugs for malaria, antibiotics for bacterial pneumonia, and oral rehydration salts for diarrhea. Vaccines protect against several causes of pneumonia and severe diarrhea, and insecticide-treated bed nets reduce malaria transmission. These tools only save lives, however, when families can reach a clinic, clinics can diagnose accurately, and the right medicines are in stock.
What is the state of prevention in Sierra Leone?
Sierra Leone has implemented the main preventive strategies recommended for these three diseases. Even so, the ICARIA findings show that current delivery is not enough to bring under-two mortality in line with regional or global targets. The country continues to post one of the world's highest child mortality rates.
The researchers point to gaps in coverage, delays in care-seeking, and limited diagnostic capacity at primary health facilities as likely contributors. Rural and remote areas typically face particular challenges, with longer travel times to facilities able to treat severe cases.
What do the findings mean for policy?
The results reinforce calls for stronger primary care, including community-based programs that can diagnose and treat the three leading killers before children become critically ill. They also highlight the need for cleaner water, better sanitation, and expanded vaccine reach.
The data add to a broader body of evidence suggesting that single-disease programs, even when well-funded, cannot on their own close child survival gaps. Integrated approaches that combine prevention, early treatment, and health system strengthening appear necessary.
What are the limits of the study?
As a prospective cohort, ICARIA follows children who agreed to participate, which may not perfectly represent the wider population. The research also cannot, on its own, prove which specific intervention would most reduce mortality; that would require separate controlled trials.
Still, the findings give policymakers a current snapshot of where Sierra Leone's youngest children are dying — and a reminder that known, affordable tools need wider, more consistent delivery.
via Medical Xpress (Source)
More from Elena Vasquez
Nearby plates
- Hydroxyurea safe for African children with sickle cell, 10-year trial finds
- HIV Services Fell Up to 72% After U.S. Aid Cuts, Study Finds
- First-in-Human Trial Reports Promising Results for Lassa Fever Vaccine
- Nearly half of injury patients in poorer countries die or face disability
- Experimental Pill Trial Aims to Slow Congo's Deadliest Ebola Outbreak